{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:20:38Z","timestamp":1791897638252,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1006\/clim.2001.5053","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"4-14","source":"Crossref","is-referenced-by-count":49,"title":["Chronic Beryllium Disease: T Cell Recognition of a Metal Presented by HLA-DP"],"prefix":"10.1006","volume":"100","author":[{"given":"Andrew P.","family":"Fontenot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee S.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Kotzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2001.5053_RF1","series-title":"Interstitial Lung Disease","first-page":"367","article-title":"Interstitial lung disorders due to beryllium and cobalt","author":"Newman","year":"1998"},{"key":"10.1006\/clim.2001.5053_RF2","first-page":"267","article-title":"Beryllium disease screening in the ceramics industry: Blood test performance and exposure-disease relations","volume":"35","author":"Kreiss","year":"1993","journal-title":"J. Occup. Med."},{"key":"10.1006\/clim.2001.5053_RF3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1164\/ajrccm\/148.4_Pt_1.985","article-title":"Epidemiology of beryllium sensitization and disease in nuclear workers","volume":"148","author":"Kreiss","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1006\/clim.2001.5053_RF4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q","article-title":"Machining risk of beryllium disease and sensitization with median exposures below 2 \u03bcg\/m3","volume":"30","author":"Kreiss","year":"1996","journal-title":"Am. J. Ind. Med."},{"key":"10.1006\/clim.2001.5053_RF5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: A genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science"},{"key":"10.1006\/clim.2001.5053_RF6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am. J. Ind. Med."},{"key":"10.1006\/clim.2001.5053_RF7","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles","volume":"163","author":"Wang","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF8","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1164\/ajrccm\/137.2.464","article-title":"The pulmonary toxicity of beryllium","volume":"137","author":"Kriebel","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1006\/clim.2001.5053_RF9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0046-8177(70)80003-X","article-title":"Beryllium disease: The relation of pulmonary pathology to the clinical course and prognosis based on a study of 130 cases from the U","volume":"1","author":"Freiman","year":"1970","journal-title":"Hum. Pathol."},{"key":"10.1006\/clim.2001.5053_RF10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease: Re-examination of disease definition and natural history","volume":"139","author":"Newman","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1006\/clim.2001.5053_RF11","doi-asserted-by":"crossref","first-page":"937S","DOI":"10.1289\/ehp.96104s5937","article-title":"The natural history of beryllium sensitization and chronic beryllium disease","volume":"104","author":"Newman","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/clim.2001.5053_RF12","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5053_RF13","first-page":"747","article-title":"Current concepts of the pathogenesis of sarcoidosis","volume":"135","author":"Thomas","year":"1987","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1006\/clim.2001.5053_RF14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1084\/jem.171.4.1123","article-title":"Biased accumulation of T lymphocytes with \u201cmemory\u201d-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung","volume":"171","author":"Saltini","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.2001.5053_RF15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","article-title":"Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells","volume":"320","author":"Saltini","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2001.5053_RF16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1165\/ajrcmb.18.4.2981","article-title":"Expansions of T-cell subsets expressing particular T cell receptor variable regions in chronic beryllium disease","volume":"18","author":"Fontenot","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1006\/clim.2001.5053_RF17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00043764-199706000-00009","article-title":"Comparison of in vivo and in vitro measures of beryllium sensitization","volume":"39","author":"Bobka","year":"1997","journal-title":"J. Occup. Environ. Med."},{"key":"10.1006\/clim.2001.5053_RF19","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/00043764-198907000-00011","article-title":"Screening blood test identifies subclinical beryllium disease","volume":"31","author":"Kreiss","year":"1989","journal-title":"J. Occup. Med."},{"key":"10.1006\/clim.2001.5053_RF20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1006\/clim.2001.5053_RF21","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0091-6749(91)90300-D","article-title":"Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease","volume":"88","author":"Mroz","year":"1991","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1006\/clim.2001.5053_RF22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-\u03b3 in berylliosis","volume":"158","author":"Tinkle","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF23","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.4049\/jimmunol.161.11.6413","article-title":"Involvement of the IP-10 chemokine in sarcoid granulomatous reactions","volume":"161","author":"Agostini","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF24","first-page":"455","article-title":"Human T-cell receptor variable gene segment families","volume":"42","author":"Arden","year":"1995","journal-title":"Immunogenetics"},{"key":"10.1006\/clim.2001.5053_RF25","doi-asserted-by":"crossref","first-page":"4428","DOI":"10.4049\/jimmunol.161.8.4428","article-title":"Selective accumulation of related CD4+ T cell clones in the synovial fluid of patients with rheumatoid arthritis","volume":"161","author":"Striebich","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF26","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.4049\/jimmunol.153.9.4291","article-title":"TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis","volume":"153","author":"Forrester","year":"1994","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF27","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1183\/09031936.98.12061463","article-title":"Immunogenetic basis of environmental lung disease: Lessons from the berylliosis model","volume":"12","author":"Saltini","year":"1998","journal-title":"Eur. Respir. J."},{"key":"10.1006\/clim.2001.5053_RF28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.285.5425.178b","article-title":"Beryllium screening raises ethical issues [news]","volume":"285","author":"Marshall","year":"1999","journal-title":"Science"},{"key":"10.1006\/clim.2001.5053_RF29","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1073\/pnas.220430797","article-title":"Beryllium presentation to CD4+ T cells underlies disease susceptibility HLA-DP alleles in chronic beryllium disease","volume":"97","author":"Fontenot","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clim.2001.5053_RF30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1399-0039.1998.tb02946.x","article-title":"Comprehensive HLA-DP typing using polymerase chain reaction with sequence-specific primers and 95 sequence-specific primer mixes","volume":"51","author":"Gilchrist","year":"1998","journal-title":"Tissue Antigens"},{"key":"10.1006\/clim.2001.5053_RF31","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/368215a0","article-title":"Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide","volume":"368","author":"Stern","year":"1994","journal-title":"Nature"},{"key":"10.1006\/clim.2001.5053_RF32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.3368786","article-title":"A molecular basis for MHC class II\u2014associated autoimmunity [published erratum appears in Science, 1988, 241(4868), 888]","volume":"240","author":"Todd","year":"1988","journal-title":"Science"},{"key":"10.1006\/clim.2001.5053_RF33","series-title":"Clinical Immunology: Principles and Practice","first-page":"94","article-title":"The major histocompatibility complex","author":"Schwartz","year":"1995"},{"key":"10.1006\/clim.2001.5053_RF34","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.4049\/jimmunol.165.6.3214","article-title":"The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder","volume":"165","author":"Stratmann","year":"2000","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0065-2776(08)60563-5","article-title":"Major histocompatibility complex-directed susceptibility to rheumatoid arthritis","volume":"68","author":"Nepom","year":"1998","journal-title":"Adv. Immunol."},{"key":"10.1006\/clim.2001.5053_RF36","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1084\/jem.181.5.1847","article-title":"Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association","volume":"181","author":"Hammer","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.2001.5053_RF37","doi-asserted-by":"crossref","first-page":"4935","DOI":"10.4049\/jimmunol.159.10.4935","article-title":"HLA-DP2: Self peptide sequences and binding properties","volume":"159","author":"Chicz","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF38","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/1529-0131(199707)40:7<1316::AID-ART17>3.0.CO;2-I","article-title":"Use of T cell receptor\/HLA-DRB1\u221704 molecular modeling to predict site-specific interactions for the DR shared epitope associated with rheumatoid arthritis","volume":"40","author":"Penzotti","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1006\/clim.2001.5053_RF39","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1034\/j.1398-9995.2000.00107.x","article-title":"Immunologic mechanisms in hypersensitivity reactions to metal ions: An overview","volume":"55","author":"Budinger","year":"2000","journal-title":"Allergy"},{"key":"10.1006\/clim.2001.5053_RF40","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.4049\/jimmunol.135.6.3929","article-title":"Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis","volume":"135","author":"Sinigaglia","year":"1985","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/1523-1747.ep12372149","article-title":"The molecular basis of metal recognition by T cells","volume":"102","author":"Sinigaglia","year":"1994","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/clim.2001.5053_RF42","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/j.1460-2075.1991.tb07648.x","article-title":"Selective interaction of Ni with an MHC-bound peptide","volume":"10","author":"Romagnoli","year":"1991","journal-title":"EMBO J."},{"key":"10.1006\/clim.2001.5053_RF43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.4049\/jimmunol.155.3.1575","article-title":"The antirheumatic drug disodium aurothiomalate inhibits CD4+ T cell recognition of peptides containing two or more cysteine residues","volume":"155","author":"Griem","year":"1995","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF44","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.4049\/jimmunol.149.8.2569","article-title":"Role of TNP-anchoring peptides in determining hapten-epitopes for MHC-restricted cytotoxic T cells: Crossreactive TNP-determinants on different peptides","volume":"149","author":"Martin","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4049\/jimmunol.151.2.678","article-title":"Structural complexity of antigenic determinants for class-I MHC-restricted, hapten-specific T cells\u2014Two qualitatively differing types of H-2K(B)-restricted TNP epitopes","volume":"151","author":"Martin","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF46","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/eji.1830271039","article-title":"Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA-DP beta chain","volume":"27","author":"Potolicchio","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF47","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2140::AID-IMMU2140>3.0.CO;2-Q","article-title":"HLA-DP molecules bind cobalt: A possible explanation for the genetic association with hard metal disease","volume":"29","author":"Potolicchio","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.iy.09.040191.002425","article-title":"MHC class-II molecules and autoimmunity","volume":"9","author":"Nepom","year":"1991","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/clim.2001.5053_RF49","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1073\/pnas.85.10.3504","article-title":"HLA class II allelic variation and susceptibility to pemphigus vulgaris","volume":"85","author":"Scharf","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clim.2001.5053_RF50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-9525(88)90135-7","article-title":"A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus","volume":"4","author":"Todd","year":"1988","journal-title":"Trends Genet."},{"key":"10.1006\/clim.2001.5053_RF51","doi-asserted-by":"crossref","first-page":"9489","DOI":"10.1073\/pnas.86.23.9489","article-title":"A specific HLA-DP beta allele is associated with pauciarticular juvenile rheumatoid arthritis but not adult rheumatoid arthritis","volume":"86","author":"Begovich","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clim.2001.5053_RF52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0198-8859(92)90101-R","article-title":"HLA-A and DPB1 loci confer susceptibility to Graves' disease","volume":"35","author":"Dong","year":"1992","journal-title":"Hum. Immunol."},{"key":"10.1006\/clim.2001.5053_RF53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-0039.1992.tb01918.x","article-title":"HLA-DP antigen and Takayasu arteritis","volume":"39","author":"Dong","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1006\/clim.2001.5053_RF54","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.4049\/jimmunol.140.6.1808","article-title":"Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides","volume":"140","author":"Celis","year":"1988","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF55","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.145.1.305","article-title":"Identification of a rabies virus T cell epitope on the basis of its similarity with a hepatitis B surface antigen peptide presented to T cells by the same MHC molecule (HLA-DPw4)","volume":"145","author":"Celis","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF56","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.146.5.1470","article-title":"Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells","volume":"146","author":"Hammond","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2001.5053_RF57","doi-asserted-by":"crossref","first-page":"6285","DOI":"10.1128\/JVI.67.10.6285-6288.1993","article-title":"Definition of an HLA-DPw2-restricted epitope on NS3, recognized by a dengue virus serotype-cross-reactive human CD4+ CD8\u2212 cytotoxic T-cell clone","volume":"67","author":"Kurane","year":"1993","journal-title":"J. Virol."},{"key":"10.1006\/clim.2001.5053_RF58","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1289\/ehp.96104s5973","article-title":"Animal models of beryllium-induced lung disease","volume":"104S","author":"Finch","year":"1996","journal-title":"Environ. Health Perspect."},{"key":"10.1006\/clim.2001.5053_RF59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/019262339702500102","article-title":"Chronic granulomatous pneumonia and lymphocytic responses induced by inhaled beryllium metal in A\/J and C3H\/HeJ mice","volume":"25","author":"Nikula","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1006\/clim.2001.5053_RF60","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/08923979709007668","article-title":"Immunologic specificity of lymphocyte cell lines from dogs exposed to beryllium oxide","volume":"19","author":"Haley","year":"1997","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1006\/clim.2001.5053_RF61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/019262339101900417","article-title":"Mechanisms of granulomatous lung disease from inhaled beryllium: The role of antigenicity in granuloma formation","volume":"19","author":"Haley","year":"1991","journal-title":"Toxicol. Pathol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661601950533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T05:15:23Z","timestamp":1680585323000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661601950533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["S1521661601950533"],"URL":"https:\/\/doi.org\/10.1006\/clim.2001.5053","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}